Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Risk factors for vascular dementia: Hypotension as a key point

Authors Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Published Date May 2008 Volume 2008:4(2) Pages 395—402

DOI http://dx.doi.org/10.2147/VHRM.S2434

Published 6 May 2008

Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Department of Internal Medicine and Clinical Neurology University of Trieste, Italy

Abstract: Physiologically, the cerebral autoregulation system allows maintenance of constant cerebral blood flow over a wide range of blood pressure. In old people, there is a progressive reshape of cerebral autoregulation from a sigmoid curve to a straight line. This implies that any abrupt change in blood pressure will result in a rapid and significant change in cerebral blood flow. Hypertension has often been observed to be a risk factor for vascular dementia (VaD) and sometimes for Alzheimer disease although not always. Indeed, high blood pressure may accelerate cerebral white matter lesions, but white matter lesions have been found to be facilitated by excessive fall in blood pressure, including orthostatic dysregulation and postprandial hypotension. Many recent studies observed among other data, that there was a correlation between systolic pressure reduction and cognitive decline in women, which was not accounted for by other factors. Baseline blood pressure level was not significantly related to cognitive decline with initial good cognition. Some researchers speculate that blood pressure reduction might be an early change of the dementing process. The most confounding factor is that low pressure by itself might be a predictor of death; nevertheless, the effect of low blood pressure on cognition is underestimated because of a survival bias. Another explanation is that clinically unrecognized vascular lesions in the brain or atherosclerosis are responsible for both cognitive decline and blood pressure reduction. We discuss the entire process, and try to define a possible mechanism that is able to explain the dynamic by which hypotension might be related to dementia.

Keywords: vascular dementia, hypotension, low blood pressure, alzheimer disease

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Depression in vascular pathologies: the neurologist's point of view

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G

Vascular Health and Risk Management 2011, 7:433-443

Published Date: 12 July 2011

Readers of this article also read:

Olmesartan/amlodipine: a review of its use in the management of hypertension

Kreutz R

Vascular Health and Risk Management 2011, 7:183-192

Published Date: 29 March 2011

Olmesartan medoxomil for the treatment of hypertension in children and adolescents

Tocci G, Volpe M

Vascular Health and Risk Management 2011, 7:177-181

Published Date: 31 March 2011

Current issues and perspectives in prenatal nutrition

Morrison JC, Elliott J, Knuppel RA, Sibai B, Pill MW

Research and Reports in Neonatology 2011, 1:25-38

Published Date: 25 May 2011

Practical issues in medication compliance in hypertensive patients

Krzesinski J, Leeman M

Research Reports in Clinical Cardiology 2011, 2:63-70

Published Date: 23 June 2011

Q fever: a new ocular manifestation

Udaondo P, Garcia-Delpech S, Salom D, Garcia-Pous M, Diaz-Llopis M

Clinical Ophthalmology 2011, 5:1273-1275

Published Date: 6 September 2011

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

Stricker RB, DeLong AK, Green CL, Savely VR, Chamallas SN, Johnson L

International Journal of General Medicine 2011, 4:639-646

Published Date: 6 September 2011

The discrediting of the monoamine hypothesis

Hinz M, Stein A, Uncini T

International Journal of General Medicine 2012, 5:135-142

Published Date: 14 February 2012

Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo

Cai L, Wang X, Wang W, Qiu N, Wen J, Duan X, Li X, Chen X, Yang L, Qian Z, Wei Y, Chen L

International Journal of Nanomedicine 2012, 7:4499-4510

Published Date: 14 August 2012